Home/Filings/4/0001555667-14-000035
4//SEC Filing

SOLAZYME INC 4

Accession 0001555667-14-000035

CIK 0001311230operating

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 5:24 PM ET

Size

8.9 KB

Accession

0001555667-14-000035

Insider Transaction Report

Form 4
Period: 2014-03-26
Transactions
  • Sale

    Common Stock

    2014-03-26$11.96/sh9,000$107,6552,528,210 total(indirect: By Trust)
Holdings
  • Common Stock

    (indirect: By Trust)
    691,739
  • Common Stock

    47,925
  • Common Stock

    (indirect: By Trust)
    54,861
  • Common Stock

    (indirect: By Trust)
    54,861
  • Common Stock

    (indirect: By Trust)
    54,861
Footnotes (7)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.76 to $12.18, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]Jazem I Family Partners, L.P.
  • [F4]The Fiddler and Alden Family Trust
  • [F5]AAF 2006 Trust
  • [F6]ESF 2006 Trust
  • [F7]ZUF 2006 Trust

Issuer

SOLAZYME INC

CIK 0001311230

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001311230

Filing Metadata

Form type
4
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 5:24 PM ET
Size
8.9 KB